Wendy Broom

907 total citations
15 papers, 188 citations indexed

About

Wendy Broom is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Wendy Broom has authored 15 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Wendy Broom's work include Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Wendy Broom is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Wendy Broom collaborates with scholars based in United States, Sweden and United Kingdom. Wendy Broom's co-authors include Peter M. Andersen, Ammar Al‐Chalabi, M. Parton, John Powell, P. Nigel Leigh, Christopher E. Shaw, Robert H. Brown, Stephan Niemann, Robert Brown and Peter C. Sapp and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Neurology.

In The Last Decade

Wendy Broom

13 papers receiving 184 citations

Peers

Countries citing papers authored by Wendy Broom

Since Specialization

Citations

This map shows the geographic impact of Wendy Broom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Broom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Broom more than expected).

Fields of papers citing papers by Wendy Broom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Broom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Broom. The network helps show where Wendy Broom may publish in the future.

Co-authorship network of co-authors of Wendy Broom

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Broom. A scholar is included among the top collaborators of Wendy Broom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Broom. Wendy Broom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Chemoprevention of hepatocellular carcinoma using N-acetylgalactosamine-conjugated siRNAs 2025 ·Disease Models & Mechanisms ·Giuseppe Maggiore, (unknown), (unknown), Purva Gopal, Lin Li, Jason Guo, (unknown), Tulin Dadali, Wendy Broom, Martin A. Maier, Hao Zhu	0
2	DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma 2024 ·PLoS Genetics ·K. Rosanna, (unknown), (unknown), (unknown), Matt Kanke, John D. Gordan, Taranjit S. Gujral, Khashayar Vakili, Manabu Nukaya, Leila Noetzli, Sean M. Ronnekleiv‐Kelly, Wendy Broom, (unknown), Praveen Sethupathy	4
3	Abstract 5924: RNAi mediated inhibition of beta-catenin demonstrates anti-tumor efficacy and immune microenvironment modulation in preclinical hepatocellular carcinoma models 2024 ·Cancer Research ·Tulin Dadali, (unknown), (unknown), Stephen B.G. Abbott, Mikyung Yu, (unknown), Brandon M. Lehrich, Satdarshan P. Monga, (unknown), Martin A. Maier, Wendy Broom	1
4	A phase 1/2a study of GEN-009, a neoantigen vaccine based on autologous peptide immune responses. 2019 ·Journal of Clinical Oncology ·Roger B. Cohen, Melissa L. Johnson, Przemyslaw Twardowski, Mark N. Stein, Ulka N. Vaishampayan, Jason R. Dobson, James J. Foti, (unknown), Louisa Dowal, Wendy Broom, Lisa K. McNeil, Thomas A. Davis, Jessica B. Flechtner	5
5	Abstract LB-223: ATLASTMreveals a dominant inhibitory antigen in melanoma patients, and a reduced breadth of tumor-associated antigen-specific T cells in non-responders to checkpoint blockade 2019 ·Cancer Research ·Louisa Dowal, Anna Lyubetskaya, Crystal Cabral, (unknown), Christopher L. Warren, James Perry, (unknown), (unknown), James J. Foti, Jessica B. Flechtner, Jason R. Dobson, F. Stephen Hodi, Wendy Broom	0
6	Systematic analysis of T cell responses specific to the Epstein-Barr virus proteome using ATLAS™ 2017 ·The Journal of Immunology ·Johanna K. Kaufmann, Biao Liu, (unknown), Ning Wu, Yan Zheng, (unknown), Christine A. Kelley, (unknown), (unknown), (unknown), Jennifer Henderson, Lila Ghamsari, Kevin C. Olivieri, Jessica B. Flechtner, Wendy Broom, Emilio Flaño, Katherine Luzuriaga	1
7	Should we refer for a dementia assessment? A checklist to help know when to be concerned about dementia in adults with Down syndrome and other intellectual disabilities 2010 ·British Journal of Learning Disabilities ·(unknown), Judith McBrien, Wendy Broom	5
8	DNA sequence analysis of the conserved region around the SOD1 gene locus in recessively inherited ALS 2009 ·Neuroscience Letters ·Wendy Broom, (unknown), Manuel Garber, Peter M. Andersen, Niall J. Lennon, John E. Landers, Chad Nusbaum, Carsten Russ, Robert H. Brown	6
9	Analysis of a genetic defect in the TATA box of the SOD1 gene in a patient with familial amyotrophic lateral sclerosis 2007 ·Muscle & Nerve ·Stephan Niemann, Wendy Broom, Robert Brown	20
10	SOD1A4V-mediated ALS: Absence of a closely linked modifier gene and origination in Asia 2007 ·Neuroscience Letters ·Wendy Broom, (unknown), (unknown), A. John Iafrate, C Russ, Ammar Al‐Chalabi, Peter C. Sapp, D. McKenna‐Yasek, Peter M. Andersen, Robert H. Brown	15
11	Two Approaches to Drug Discovery in SOD1-Mediated ALS 2006 ·SLAS DISCOVERY ·Wendy Broom, (unknown), Jake Ni, (unknown), Li-An Yeh, Michele M. Maxwell, Marcie A. Glicksman, Aleksey Kazantsev, Robert H. Brown	21
12	Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes 2005 ·Neuroscience Letters ·Wendy Broom, Carsten Russ, Peter C. Sapp, Diane McKenna‐Yasek, Betsy A. Hosler, Peter M. Andersen, Robert H. Brown	16
13	Inhibition of SOD1 expression by mitomycin C is a non-specific consequence of cellular toxicity 2005 ·Neuroscience Letters ·Wendy Broom, İlknur Ay, Piera Pasinelli, Robert H. Brown	5
14	No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS 2004 ·Neurology ·Wendy Broom, M. Parton, Caroline Vance, C Russ, Peter M. Andersen, Valerie K. Hansen, P. Nigel Leigh, John Powell, Ammar Al‐Chalabi, Christopher E. Shaw	9
15	D90A-SOD1 mediated amyotrophic lateral sclerosis: A single founder for all cases with evidence for aCis-acting disease modifier in the recessive haplotype 2002 ·Human Mutation ·M. Parton, Wendy Broom, Peter M. Andersen, Ammar Al‐Chalabi, P. Nigel Leigh, John Powell, Christopher E. Shaw	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact